6
accuse
inhibitors
advisory panel
guidant
heart attack
shares in gw
iressa
idec
regulators
drug
sclerosis
lung cancer
firm
bat
cas
sclerosis drug
protein
open letter
hopes
stent
drug testing
advisory
fights
multiple sclerosis
testing
cannabis
sandoz
astrazeneca
stroke
heart
lung
saliva
drugmakers
clinical
food and drug
eli lilly
iressa drug
risk
pharma
biogen
